Protocol Ledger

NCT04355767 · Phase III · COMPLETED

Convalescent Plasma in Outpatients With COVID-19

Interventional Phase III clinical trial protocol NCT04355767 sponsored by Stanford University in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-08-11 Enrollment: 511 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04355767
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)511 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04355767
Protocol FieldVerified Registry Value
NCT IdentifierNCT04355767
Consolidated Lead SponsorStanford University
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment511 participants (ACTUAL)
Registered Start Date2020-08-11
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI